Similarly, the levels of the chemokine CXCL12 were elevated in the synovium and bone tissue of RA patients, and it has a pronounced activating effect on mature osteoclasts by inducing bone resorption activity and specific MMP-9 enzyme release [40]. The gene discussed is MMP9; the disease is rheumatoid arthritis.